You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
High-speed, portable reflectance confocal microscope (pRCM) for imaging skin cancer
SBC: ARGOSMD, INC. Topic: 102Project Summary/Abstract The current standard of care for skin cancer diagnosis, biopsy, is invasive, slow, and burdensome in cost. Skin cancer is the most commonly diagnosed cancer in the US. Biopsy of suspicious skin lesion is the key step of skin cancer diagnosis. 15-20 million skin biopsies are performed in the US annually. Once biopsied tissue is removed from a patient, the biopsy specimen is ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Leveraging platelet signal transduction for personalized antiplatelet therapy
SBC: PlateletDiagnostics, LLC Topic: NHLBIProject Summary/Abstract Platelet-mediated thrombosis causes both coronary arterial disease (CAD) and stroke, the first and fifth most common causes of mortality in the US. Antiplatelet agents, typically aspirin and/or clopidogrel, significantly improve survival in patients with CAD or stroke and have remained a mainstay of treatment for more than two decades. Yet despite the consensus that platel ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin
SBC: NEUIMMUNE BIOLOGICS, INC. Topic: NHLBIABSTRACTAlpha-1 antitrypsin (A1AT) is well-established as a biotherapeutic used for the treatment of alpha-1 antitrypsin deficiency, and shows promise for treating a variety of other diseases. However, A1AT augmentation therapy carries unnecessary risk since it relies upon the weekly transfusion of plasma-derived product, which presents supply chain and contaminant risks. This could be remedied wi ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
The First Non-Surgical Anti-Stomal Prolapse Medical Device to Treat and Prevent Stomal Prolapse
SBC: PEDIATRIC MEDICAL DEVICE COMPANY, LLC Topic: 300ABSTRACT Intestinal stomas such as ileostomies and colostomies are openings of the intestinal tract surgically exteriorized onto the abdominal surface to divert enteric content away from distal cancer, obstruction, inflammation, and infection 5. In the US alone, about 1.5 million people have stomas14. Prolapse, or protrusion, of the bowel through the stoma is a common complication that can cause p ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development and characterization of HIV-1 Tat degraders
SBC: Thimble Therapeutics Inc Topic: NIAIDAbstractDespite effective antiretroviral therapy (ART), latent proviruses can reinitiate viral production upon cell stimulation or treatment interruption. The viral Tat protein enhances transcript elongation from the HIV-1 promoter, controlling the switch between latency and active viral production. The block-and-lock functional cure aims at the transcriptional silencing of the viral reservoir, re ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Clinical Decision Support System to Optimize Neonatal Nutrition and Growth
SBC: Medical Predictive Science Corporation Topic: NICHDProject Summary/Abstract: Clinical Decision Support System to Optimize Neonatal Nutrition and Growth Nutrition, defined as energy, macronutrients (protein, fat, and carbohydrates), and micronutrients (e.g., electrolytes), is a critical feature of care for preterm infants in the neonatal intensive unit (NICU). Inadequate nutrition is associated with growth and neurodevelopmental impairment, and inc ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development and Evaluation of an Integrated Biomarker Capture System for Use in Remote Trials
SBC: MOUNTAINPASS TECHNOLOGY LLC Topic: NCATSABSTRACT Remote trials are led and coordinated by a local investigative team, but are based remotely, typically in the participant’s home. Remote trials offer several advantages over traditional in-person trials including: 1) a wider participant pool, 2) reduced regulatory hurdles, and 3) reduced participant burden. Remote trials face one key methodological limitation: the need for biomarker col ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow
SBC: Sigray, Inc. Topic: 400Project Summary/Abstract Low oxygen (hypoxic) environments are known to be important for maintaining the small number of adult stem cells in the human body, such as in bone marrow. These conditions are also believed to enable dormant cancer cells to survive and metastasize years or decades after the original tumor has been destroyed and the reason why bone marrow is one of the most common sites of ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Protease Stable N-Terminally Modified Therapeutic Peptides
SBC: VELUM INC Topic: NIDDKPROJECT SUMMARY Peptide therapeutics combine high potency and selectivity, and engender fewer side effects than traditional small molecules. This has fueled interest in peptides filling the gap between ‘biologics’ and small molecules, as peptide-based compounds have key desired properties that are distinct both of the other classes. A major challenge remains to extend the short half-life of na ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
A web-based platform to support team-based genome diagnostics
SBC: FRAMESHIFT LABS INC Topic: 172Summary/Abstract Genomic sequencing is rapidly becoming a standard tool in diagnosing complex diagnostic cases, especially in critically ill newborns, and patients suffering from rare diseases. Current programs focused on addressing these cases utilise a team-based approach to identify, interpret and evaluate a patient’s genetic variants. These diverse teams include bioinformaticians, medical ge ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health